NeoMatrix Halo
Client Snapshot
HALO® Breast Pap Test
The HALO® Breast Pap Test is a patented fully automated noninvasive breast disease-screening device for use in physician offices. It is FDA-cleared for the collection of nipple aspirate fluid (NAF) for cytological evaluation. Like the Pap test for cervical cancer, HALO looks for cellular changes years before breast cancer is detectable by mammographic imaging.
Explore Other Case Studies
StarFish Medical helped Canary Medical develop a smart implantable screw using EIS to monitor fracture healing without repeated imaging.
LumiThera chose StarFish Medical for their expertise in navigating the path from late-stage prototype to commercial launch.
Theranostics represent a promising new frontier in cancer treatment, offering hope alongside a unique set of challenges for healthcare providers.
A leading research institution tackling the challenge of motor neuron degeneration in ALS developed a novel approach to treatment: deliver GDNF-secreting neural progenitor cells directly into the spinal cord to provide sustained neurotrophic support.
Explore Our Services
Our multidisciplinary teams have all the in-house capabilities to transform your medical device from concept to final product.
Medical device design and development with a commercial launch focus. See how we support clinical trials and facilitate seamless tech transfers.
We help you navigate complex regulatory landscapes to achieve commercial success. Explore our integrated approach to quality and regulatory services.